Stay updated with breaking news from Holger moch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PathAI, a global leader in AI-powered pathology, today announced a new Early Access Program (EAP) to drive adoption of its AISightTM Image Management System (IMS) in Mainland Europe.1 Earlier in 2023, PathAI announced a similar program for. ....
ESOU 2021: Histological Classification and Immunophenotyping of Renal Tumors (UroToday.com) The third renal cancer session at the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting focused on the management of patients with advanced and metastatic disease. In this session, Dr. Holger Moch presented on the histological classification and immunophenotyping of renal tumors. Dr. Moch began by discussing the 2016 World Health Organization (WHO) classification of malignant epithelial renal tumors, of which there are 14 types, despite the fact that clinical practice focused on clear cell, papillary, and chromophobe. Clear cell renal cell carcinoma (ccRCC) is the predominant subtype clinically and thus forms the preponderance of disease treated on trials. Dr. Moch highlighted that differing phenotypes of these tumors (hypervascular, immunogenic, and metabolic) lend differing sensitivity to a variety of systemic therapy app ....